Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 1 Rating

Total
ease
features
design
support

Description

Amedea Pharma presents a range of cutting-edge solutions aimed at improving the effectiveness and standards of Medical Affairs within the life sciences industry. At the forefront of their offerings is the ANCORA Decision Assistant Platform, a SaaS tool that leverages an innovative DeepMetrics approach, merging elements of sports analytics with data science to optimize business functions. This platform has successfully undergone beta testing during two significant drug launches, showcasing remarkable enhancements such as efficiency gains of up to 141%, productivity increases reaching as high as 416%, and a notable 25% decrease in employee costs. In addition, Amedea Pharma has developed a generative AI-driven medical insights platform that uses large language models to support natural conversational queries, meeting summaries, and actionable insights. Their suite of professional services also includes crafting an extensive medical affairs metrics playbook and orchestrating internal innovation events inspired by their annual Medical Affairs Innovation Olympics, fostering a culture of creativity and advancement within the organization. Through these initiatives, Amedea Pharma aims to redefine the landscape of medical affairs and drive significant value for their clients.

Description

Cruxi is a specialized vertical AI platform designed for teams involved in the regulatory processes of medical devices. It efficiently processes a variety of sources, including FDA regulations, guidance documents, product codes, standards, MAUDE events, recalls, and historical 510(k) submissions to enhance workflows related to 510(k), De Novo, and eSTAR applications. Users benefit from the ability to quickly classify devices, analyze predicates, strategize evidence presentation, and create fully referenced content that aligns with the requirements of eSTAR for each part of their submission. The platform not only provides comprehensive submission workflows but also offers targeted micro-services, such as classification, predicate evaluation, and drafting of specific sections. This versatility makes Cruxi particularly valuable for early-stage startups, in-house regulatory teams, and consultants, enabling them to produce high-quality submissions while minimizing manual effort and reducing unforeseen challenges with the FDA. By streamlining the regulatory submission process, Cruxi ultimately helps organizations navigate the complexities of compliance more effectively.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

Credit-based system
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Amedea Pharma

Founded

2016

Country

United States

Website

amedeapharma.com/solutions

Vendor Details

Company Name

Cruxi

Founded

2024

Country

United States

Website

cruxi.ai

Product Features

Product Features

Alternatives

ACMA Engage Reviews

ACMA Engage

Accreditation Council for Medical Affairs (ACMA)

Alternatives

RAMS Reviews

RAMS

Emergo by UL
waiting Reviews

waiting

Python Software Foundation
MedAffairs AI Reviews

MedAffairs AI

Accreditation Council for Medical Affairs (ACMA)